복강경 부인과 수술 시장 : 시장 규모, 점유율 및 동향 분석 보고서 - 수기별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report By Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy), By End Use (Clinics, ASCs, Hospitals), By Region, And Segment Forecasts, 2025 to 2030

US $ 5,950 ￦ 8,833,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,318,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,288,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

복강경 부인과 수술 시장 요약

세계의 복강경 부인과 수술 시장 규모는 2024년 199억 달러로 평가되었고, 2030년까지 240억 달러에 이를 것으로 예측됩니다.

2025-2030년 CAGR 3.2%로 성장할 것으로 예측됩니다. 복강경 부인과 수술은 회복 기간의 단축과 흉터의 경감을 요구하는 환자의 의향, 자궁근종 및 자궁내막증 등 부인과 질환의 유병률 상승, 로봇 지원 수술을 포함한 기술 진보를 배경으로 저침습 수술의 채용 확대에 의해 성장하고 있습니다.

저침습 수술(MIS)에 대한 선호 증가가 복강경 부인과 수술의 보급 확대의 주요 촉진요인이 되고 있습니다. 특히 자궁내막증, 자궁근종, 난소낭종, 자궁외임신 등의 질환 치료에 있어서 현저합니다. 복강경 부인과 수술은 회복기간 단축, 입원일수 감소, 수술후 합병증 감소, 최소한의 흉터 형성을 실현하며 현대 의료에서 환자 중심의 동향을 따릅니다. 마찬가지로, 의료 제공업체에게는 수술실의 회전 효율 향상 및 수술 후 케어 수요의 감소가 외래수술센터(ASC)와 외래 부인과 클리닉에서 수술 건수 증가를 촉진하고, 복강경 수술에 대한 선호를 높이고 있습니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 복강경 부인과 수술 시장의 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 복강경 부인과 수술 시장 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 복강경 부인과 수술 시장 : 수기별 추정 및 동향 분석

• 부문 대시보드
• 세계의 복강경 부인과 수술 시장 : 수기별 변동 분석
• 세계의 복강경 부인과 수술 시장 규모 및 동향 분석 : 수기별(2018-2030년)
• 복강경 자궁적출술
• 복강경 부속기
• 복강경 자궁내막 절제술
• 복강경에 의한 진단 절차
• 복강경 자궁근종 절제술
• 복강경 질고정술

제5장 복강경 부인과 수술 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 세계의 복강경 부인과 수술 시장 : 최종 용도별 변동 분석
• 세계의 복강경 부인과 수술 시장 규모 및 동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 클리닉
• 외래수술센터(ASC)

제6장 복강경 부인과 수술 시장 : 수기별 및 최종 용도별 지역별 추정 및 동향 분석

• 지역별 시장 점유율 분석(2025년, 2030년)
• 지역별 시장 대시보드
• 세계 지역 시장 현황
• 시장 규모, 예측 및 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출 기업에 의한 최근의 동향 및 영향 분석
• 기업 및 경쟁 분류
• 주요 기업의 시장 점유율 분석(2025년)
• 기업 포지션 분석
• 기업의 분류(신흥기업, 이노베이터, 리더)
• 기업 프로파일
  • Medtronic
  • Stryker
  • Karl Storz SE & CO. Kg
  • Johnson and Johnson
  • Olympus Corporation
  • CONMED Corporation
  • B. Braun SE
  • CooperCompanies
  • Richard Wolf GmbH
  • Microline Surgical
  • Welfare Medical Ltd.
  • Intuitive Surgical
  • Shenzhen Mindray Bio Medical Electronics Co., Ltd.

AJY

영문 목차

영문목차

Laparoscopic Gynecological Procedures Market Summary

The global laparoscopic gynecological procedures market size was estimated at USD 19.9 billion in 2024 and is projected to reach USD 24.0 billion by 2030, growing at a CAGR of 3.2% from 2025 to 2030. Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for reduced recovery times and less scarring, the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis, and technological advancements, including robotic-assisted surgery.

The growing preference for minimally invasive surgeries (MIS) is a primary driver for the rising adoption of laparoscopic gynecological procedures, particularly in the treatment of conditions such as endometriosis, fibroids, ovarian cysts, and ectopic pregnancies. Laparoscopic gynecology offers shorter recovery times, reduced hospital stays, lower post-operative complications, and minimal scarring, which align with patient-centric trends in modern healthcare. Similarly, for healthcare providers, the increased efficiency in operating room (OR) turnover and reduced postoperative care demand are driving procedural volumes in ambulatory surgical centers (ASCs) and outpatient gynecology clinics, which is increasing their preference towards laparoscopic procedures.

Global Laparoscopic Gynecological Procedures Market Report Segmentaton

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laparoscopic gynecological procedures market based on procedure, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Laparoscopic Hysterectomy
• Laparoscopic Adnexal
• Laparoscopic Endometrial Excision
• Laparoscopic Diagnostic Procedures
• Laparoscopic Myomectomy
• Laparoscopic Colpopexy
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Laparoscopic Gynecological Procedures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Laparoscopic Gynecological Procedures Procedure Market Movement Analysis
• 4.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
• 4.4. Laparoscopic Hysterectomy
  • 4.4.1. Laparoscopic Hysterectomy market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Laparoscopic Adnexal
  • 4.5.1. Laparoscopic Adnexal market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Laparoscopic Endometrial Excision
  • 4.6.1. Laparoscopic Endometrial Excision market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Laparoscopic Diagnostic Procedures
  • 4.7.1. Laparoscopic Diagnostic Procedures market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Laparoscopic Myomectomy
  • 4.8.1. Laparoscopic Myomectomy market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Laparoscopic Colpopexy
  • 4.9.1. Laparoscopic Colpopexy market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Laparoscopic Gynecological Procedures End Use Market Movement Analysis
• 5.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals' market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Clinics
  • 5.5.1. Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Ambulatory Surgery Centers market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis By Procedure, End Use

• 6.1. Regional Market Share Analysis, 2025 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement structure
    • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement structure
    • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement structure
    • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement structure
    • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement structure
    • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement structure
    • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework
    • 6.6.4.4. Reimbursement structure
    • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework
    • 6.6.5.4. Reimbursement structure
    • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework
    • 6.6.6.4. Reimbursement structure
    • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework
    • 6.6.7.4. Reimbursement structure
    • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework
    • 6.6.8.4. Reimbursement structure
    • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement structure
    • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement structure
    • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement structure
    • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement structure
    • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement structure
    • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement structure
    • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement structure
    • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement structure
    • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement structure
    • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement structure
    • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework
    • 6.9.3.4. Reimbursement structure
    • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework
    • 6.9.4.4. Reimbursement structure
    • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2025
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators and Leaders)
• 7.6. Company Profiles
  • 7.6.1. Medtronic
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Stryker
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. Karl Storz SE & CO. Kg
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Johnson and Johnson
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Olympus Corporation
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. CONMED Corporation
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. B. Braun SE
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. CooperCompanies
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Richard Wolf GmbH
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. Microline Surgical
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives
  • 7.6.11. Welfare Medical Ltd.
    • 7.6.11.1. Company overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Product benchmarking
    • 7.6.11.4. Strategic initiatives
  • 7.6.12. Intuitive Surgical
    • 7.6.12.1. Company overview
    • 7.6.12.2. Financial performance
    • 7.6.12.3. Product benchmarking
    • 7.6.12.4. Strategic initiatives
  • 7.6.13. Shenzhen Mindray Bio Medical Electronics Co., Ltd.
    • 7.6.13.1. Company overview
    • 7.6.13.2. Financial performance
    • 7.6.13.3. Product benchmarking
    • 7.6.13.4. Strategic initiatives

관련자료